NK012 phase II clinical study
Latest Information Update: 09 Sep 2019
At a glance
- Drugs NK 012 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Nippon Kayaku
- 02 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.